The treatment of Cataracts & Vertigo with vitamins

Cataracts and Vertigo: Mitamins custom make quality formulas for the treatment of Cataracts & Vertigo with vitamins. A Cataracts & Vertigo formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Vertigo

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Vitamin B6
    50
    mg
    2500%
    Selenium
    200
    mcg
    286%
    Inositol
    50
    mg
    *
  • Amount Per Serving
    % DV
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cataracts and Vertigo
Monthly Cost: $31.12
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Cataracts and Vertigo Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Erectile Dysfunction: A Harbinger of Heart Trouble (HealthDay)
Few men may realize it, but if they're having problems achieving or sustaining erections, it may signal underlying heart trouble.
New Analysis Of Data Shows Treatment With Abbott's HUMIRA® Significantly Reduced Disease-Related Hospitalization For Patients With Crohn's
Abbott today announced results from a post-hoc analysis of a pivotal study presented at the Digestive Disease Week annual meeting in Washington, D.C. showing patients with moderate to severely active Crohn's disease treated with HUMIRA® (adalimumab) maintenance therapy were almost 60 percent less likely than patients on placebo to be hospitalised due to their disease at one year (5.9 percent versus 13.9 percent; p
This information concerning the support of Cataracts and Vertigo treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Eye & Vision  Cataracts  Cataracts and Vertigo
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments